Geneos Wealth Management’s VanEck CLO ETF CLOI Stock Holding History

Geneos Wealth Management’s Portfolio CLOI Stock Details CLOI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$9.45M	Sell	178,384 -17,331	-9%	-$915K	0.19%	124
2026 Q1	$10.3M	Buy	195,715 +38,797	+25%	+$2.05M	0.24%	95
2025 Q4	$8.29M	Sell	156,918 -5,010	-3%	-$265K	0.2%	128
2025 Q3	$8.6M	Buy	161,928 +8,425	+5%	+$446K	0.22%	117
2025 Q2	$8.13M	Buy	153,503 +34,036	+28%	+$1.79M	0.2%	130
2025 Q1	$6.31M	Buy	119,467 +109,883	+1,147%	+$5.82M	0.21%	115
2024 Q4	$506K	Buy	+9,584	New	+$508K	0.02%	586

Other funds holding CLOI

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

IAA

Independence Asset Advisors Wynnewood,, Pennsylvania $384M AUM 10.81% 1-Year Est. Return

CIA

Capital Investment Advisors Atlanta, Georgia $7.59B AUM 23.38% 1-Year Est. Return

TPWA

TRUE Private Wealth Advisors Salem, Oregon $1.16B AUM 36.18% 1-Year Est. Return

BCI

Brinker Capital Investments Berwyn, Pennsylvania $13.1B AUM 28.37% 1-Year Est. Return

SWA

Sax Wealth Advisors Parsippany, New Jersey $2.46B AUM 19.75% 1-Year Est. Return

DMBA

Deseret Mutual Benefit Administrators Salt Lake City, Utah $306M AUM 35.77% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Jones Financial Companies Des Peres, Missouri $250B AUM 21.32% 1-Year Est. Return

Gradient Investments Arden Hills, Minnesota $7.25B AUM 20.71% 1-Year Est. Return

Geneos Wealth Management's CLOI Position: Q2 2026 in Review

Geneos Wealth Management reduced its VanEck CLO ETF (CLOI) stake by 8.9% in Q2 2026, selling an estimated $915K and leaving 178,384 shares worth $9.45M. The position accounts for 0.19% of the portfolio, ranked #124.

Geneos Wealth Management first reported a position in CLOI in Q4 2024 and has held it in 7 quarters since. The position peaked at $10.3M in Q1 2026. 197 funds tracked by Wall St. Rank hold CLOI as of Q2 2026.

Geneos Wealth Management held 178,384 shares of VanEck CLO ETF worth $9.45M as of Q2 2026.
Geneos Wealth Management sold 17,331 VanEck CLO ETF shares in Q2 2026, an estimated $915K.
VanEck CLO ETF made up 0.19% of Geneos Wealth Management's portfolio in Q2 2026, its #124 holding.
Geneos Wealth Management first reported a position in VanEck CLO ETF in Q4 2024 and has held it in 7 quarters since.
Geneos Wealth Management's VanEck CLO ETF position peaked at $10.3M in Q1 2026.
197 funds tracked by Wall St. Rank held VanEck CLO ETF as of Q2 2026.

Based on Geneos Wealth Management's 13F filing for Q2 2026, filed 6 Aug 2026.